PHARMACYTE BIOTECH INC's ticker is PMCBD and the CUSIP is 71715X203. A total of 29 filers reported holding PHARMACYTE BIOTECH INC in Q4 2021. The put-call ratio across all filers is 2.44 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2023 | $75 | -29.2% | 25,600 | -29.7% | 0.00% | – |
Q4 2022 | $106 | -99.9% | 36,400 | -22.6% | 0.00% | – |
Q3 2022 | $113,000 | -19.3% | 47,000 | -24.2% | 0.00% | – |
Q2 2022 | $140,000 | -22.2% | 62,000 | -20.6% | 0.00% | – |
Q1 2022 | $180,000 | -7.7% | 78,100 | 0.0% | 0.00% | – |
Q4 2021 | $195,000 | -54.0% | 78,100 | -41.5% | 0.00% | – |
Q3 2021 | $424,000 | – | 133,600 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
SABBY MANAGEMENT, LLC | 1,217,828 | $3,045,000 | 0.44% |
Ayrton Capital LLC | 153,130 | $383,000 | 0.36% |
Shay Capital LLC | 662,337 | $1,656,000 | 0.27% |
EQUITEC PROPRIETARY MARKETS, LLC | 258,694 | $647,000 | 0.09% |
Anson Funds Management LP | 193,400 | $484,000 | 0.05% |
SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC | 44,944 | $112,000 | 0.00% |
Jump Financial, LLC | 10,300 | $26,000 | 0.00% |
Schonfeld Strategic Advisors LLC | 30,400 | $76,000 | 0.00% |
Aspire Private Capital, LLC | 800 | $2,000 | 0.00% |
OSAIC HOLDINGS, INC. | 1,763 | $5,000 | 0.00% |